Brian Olshansky

Dept of Cardiac Electrophysiology, University of Iowa Hospitals, United States of America

Brian Olshansky is tenured Professor of Medicine and Director of Cardiac Electrophysiology at the University of Iowa Hospitals. He directs the Clinical Cardiac Electophysiology Fellowship Training Program.

He is recognized for work regarding arrhythmia mechanisms, treatment of atrial and ventricular arrhythmias and evaluation of syncope. His diverse interests range from technological and mechanistic aspects of cardiac electrophysiology to holistic and ethical issues. Professor Olshansky is presently the Principal Investigator and originator of the INTRINSIC RV trial and is involved with magnetic based technologies regarding catheter and lead positioning. He has expertise in the evaluation and treatment of cardiac arrhythmias using state of the art techniques including: device implantation (pacemakers and implanted defibrillators), catheter ablation techniques, including for atrial fibrillation and ventricular tachycardia. He is an internationally known expert in his field and has pursued many avenues of research.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Cardiovascular Disorders > Arrhythmias, Electrophysiology & Pacing (since 09 November 2005)

All recent recommendations

• 3.0
  Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.
  Recommended by Brian Olshansky with Rakesh Gopinathannair
  
• 3.0
  Increased mortality after dronedarone therapy for severe heart failure.
  Recommended by Brian Olshansky with Rakesh Gopinathannair
  
• 9.8
  Rhythm control versus rate control for atrial fibrillation and heart failure.
  Recommended by Brian Olshansky with Chirag Sandesara, Wilbert Aronow, Hector Ventura with Anil Verma
  
• 6.0
  Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.
  Recommended by Brian Olshansky with Chirag Sandesara
  
• 6.0
  Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.
  Recommended by Brian Olshansky
  
• 3.0
  Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
  Recommended by Brian Olshansky
  
• 3.0
  Ventricular arrhythmias during Tako-tsubo syndrome.
  Recommended by Brian Olshansky
  
• 6.0
  Resting heart rate in cardiovascular disease.
  Recommended by Brian Olshansky
  
• 3.0
  Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia?
  Recommended by Brian Olshansky
  
• 3.0
  Sympathoadrenergic overstimulation in Tako-Tsubo cardiomyopathy triggered by physical and emotional stress.
  Recommended by Brian Olshansky
  
• 3.0
  Trials and travails of electrogram-guided ablation of chronic atrial fibrillation.
  Recommended by Brian Olshansky
  
• 3.0
  The expectation effect and cardiac pacing for refractory vasovagal syncope.
  Recommended by Brian Olshansky
  
• 3.0
  Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial.
  Recommended by Brian Olshansky
  
• 3.0
  A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.
  Recommended by Brian Olshansky
  
• 3.2
  Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.
  Recommended by Patrick Wouters, Brian Olshansky
  
• 3.0
  Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.
  Recommended by Brian Olshansky
  
• 6.0
  Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
  Recommended by Brian Olshansky
  
• 6.0
  Arrhythmogenic right ventricular dysplasia: a United States experience.
  Recommended by Brian Olshansky